Ionizing radiation leads to rapid stabilization and activation of the p53 tumor suppressor. Previous reports demonstrate that murine p19ARF cooperates with p53 in the cellular response to gamma irradiation. Here, we show that endogenous ARF sequentially interacts with p53 and MDM2 following irradiation of primary human and mouse embryonic fibroblasts. Shortly after irradiation, p14ARF binds p53 independently of MDM2. As nuclear pools of p53 decline, endogenous p14ARF co-immunoprecipitates with MDM2 and is localized within the nucleolus. Interestingly, p14ARF nucleolar localization during this response is abrogated in cells lacking functional p53. Taken together, our data suggest that human and murine ARF contribute to the mammalian DNA damage response.
Introduction
The p53 tumor suppressor is activated via diverse stress signals including DNA damage, hypoxia and ribonucleotide depletion (Kastan et al., 1991; Huang et al., 1996; Linke et al., 1996) . p53 relies on upstream and downstream regulators for correct function (Giaccia and Kastan, 1998) . Because p53 promotes growth arrest or apoptosis, modulation of p53 activity is critical for survival. Thus, p53 function and stability are regulated by MDM2 (HDM2 in humans), which inhibits p53-mediated transactivation and promotes p53 degradation (Momand et al., 1992; Haupt et al., 1997; Kubbutat et al., 1997; Thut et al., 1997) . The major target of MDM2 is p53, as demonstrated by embryonic lethality of MDM2 nullizygous mice, a phenotype rescued by inactivating p53 (Jones et al., 1995; Montes de Oca Luna et al., 1995) . Interestingly, p53 induces MDM2 expression, generating an autoregulatory feedback loop (Wu et al., 1993) . Hence, countermeasures must be in place to prevent downregulation of p53 when activation of cell cycle arrest or apoptosis is appropriate.
P53 is rapidly induced following exposure to ionizing radiation (IR) in wild-type mouse embryonic fibroblasts (MEFs). However, p53 induction is neither acute nor sustained in irradiated ARFÀ/À MEFs, suggesting that p19ARF cooperates with p53 in response to DNA damage (Khan et al., 2000) . Similar to ATMÀ/À and Chk2À/À MEFs, cell cycle profiling reveals that the majority of ARFÀ/À MEFs continue cycling post-IR (Khanna and Lavin, 1993; Xu and Baltimore, 1996; Hirao et al., 2000) . Further evidence linking ARF with DNA damage responses came from the in vivo observation that irradiated ARF-null mice have an increased tumor frequency compared to wild-type mice, suggesting that ARF suppresses tumor growth upon genetic insult (Kamijo et al., 1999a) . Recent data have also suggested that ARF, p53 and Rad6 form a supramolecular complex in response to adriamycin or cisplatin treatment (Lyakhovich and Shekhar, 2003) .
In addition to DNA damage responses, data from several laboratories suggest that ARF promotes p53 stabilization and prevents cell cycle progression in response to oncogenic activation. Enforced expression of E1A, ras, myc or E2F-1 leads to an increase in the cellular levels of ARF and stabilization of p53 de Stanchina et al., 1998; Palmero et al., 1998; Zindy et al., 1998; Groth et al., 2000) .
Several models of ARF function have been proposed. ARF can bind to and directly ablate the function of MDM2 Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998) . ARF also blocks the ubiquitin ligase activity of MDM2 toward p53 in vitro (Honda and Yasuda, 1999; Midgley et al., 2000) . An alternate model proposes that ARF promotes p53 stability by sequestration of MDM2 into nucleolar compartments (Weber et al., 1999 . Yet, other reports show that ARF promotes p53 stabilization and cell cycle arrest without nucleolar accumulation with MDM2 (Llanos et al., 2001; Korgaonkar et al., 2002) . One report demonstrates that ARF function can be exerted via direct p53/ARF interaction, as murine p19ARF binds p53/DNA complexes in an MDM2-independent manner .
Current models suggest that ectopically expressed ARF binds p53 and MDM2, yet the exact timing of these interactions, at physiological expression levels, during a stress response, has not been well characterized Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998) . While murine ARF has been implicated in the cellular response to IR, it is not known whether ARF forms complexes with p53 or MDM2 during this response.
Endogenous pools of p53 and MDM2 are rapidly induced and tightly regulated after irradiation, setting up a physiological system in which to analyse the biochemical interactions between ARF, p53 and MDM2 following DNA damage. We demonstrate here that human and murine ARF associate transiently with p53 and MDM2 in a temporally separable manner after irradiation.
Results p19ARF transiently associates with p53 and MDM2 following irradiation p19ARF is required to promote cell cycle arrest of irradiated murine fibroblasts (Khan et al., 2000) . Current models predict that p19ARF must interact with p53 and/or MDM2 during this response in order to induce cell cycle arrest. Thus, early-passage, wild-type MEFs were irradiated at 7 Gy and harvested at several time points post-IR.
p53 and MDM2 levels were elevated in irradiated MEFs relative to untreated populations, whereas p19ARF levels remained relatively constant over the duration of the time course (Figure 1a ). Immunoprecipitation of p19ARF revealed an interaction between p53 and p19ARF within 2 h of irradiation, whereas p53 is undetectable in ARF immune complexes isolated from nonirradiated cells (Figure 1b) . Formation of p19ARF/ p53 complexes is rapid and transient, as p53 is not detected within ARF immune complexes at later time points (Figure 1b) . Whereas MDM2 induction appears to peak 4 h after IR, the peak p19ARF/MDM2 complex formation was not detected until 6-8 h after irradiation (Figure 1b) . p14ARF transiently associates with p53 and HDM2 following IR To assess whether human p14ARF responds similarly to IR, WS1 human diploid fibroblasts were irradiated at 7 Gy and harvested at various time points following treatment. Immunoblotting of whole-cell extracts with p53 and HDM2 antisera showed that p53 levels are maximal within 2 h of irradiation, whereas HDM2 induction shows delayed kinetics (Figure 1c ). In common with murine p19ARF, human p14ARF levels remained relatively unchanged during the time course, as assessed by Western blotting (Figure 1c) .
Anti-p14ARF immunoprecipitations were performed on lysates prepared from irradiated or untreated WS1, followed by Western blotting with p53 and HDM2 antisera. IR-induced interactions between p14ARF, p53 and HDM2 in WS1 fibroblasts were readily detectable (Figure 1d) . Significantly, the peak of p14ARF/p53 association occurred within 2 h of irradiation in WS1, whereas p14ARF/HDM2 binding was maximal at 4 h ( Figure 1d ). Peak levels of ARF/p53 complexes consistently preceded those of ARF/HDM2, following IR. Moreover, the accumulation of p14ARF/HDM2 complexes at 4 h coincided with a decrease in detectable p53. Similar results were obtained in normal human lung fibroblasts (data not shown).
ARF re-localizes during the IR response
Several reports suggest that overexpressed pools of p19ARF accumulate in the nucleolus (Weber et al., 1999; Zhang and Xiong, 1999; Llanos et al., 2001) . Endogenous p19ARF also accumulates in the nucleolus during cellular senescence and upon overexpression of oncogenes (Weber et al., 1999 Zhang and Xiong, 1999) .
Staining of untreated, early-passage MEFs with antip19ARF antibodies revealed diffuse staining, distributed throughout the nucleus ( Figure 2A , panels a, b). At 2-4 h post-IR, the majority of the p19ARF signal is detectable in large subnuclear domains, reminiscent of nucleoli, although some signal is still detectable within the nucleoplasm (Figure 2A , panels c-f). At 6-8 h post-IR, the majority of the p19ARF signal accumulates Figure 1 IR induces complex formation between p19ARF, p53 and Mdm2. Early passage (p4) wild-type MEFs were left untreated (T0) or irradiated at 7 Gy and harvested after 2 (T2), 4 (T4), 6 (T6) and 8 h (T8). (a) Whole-cell lysates (100 mg) were separated on a 4-20% polyacrylamide gradient gel. After Western transfer, blots were probed for p19ARF, p53 and Mdm2. To verify equal protein loading, the blot was probed with actin antisera. (b) p19ARF immunoprecipitations were performed using 1 mg lysate per time point and immune complexes were resolved on 4-20% gradient SDS-PAGE. Blots were probed with p53 and Mdm2 antibodies. (c) WS1 fibroblasts were treated with 7 Gy IR and harvested after 2 (T2), 4 (T4) and 8 h (T8). Whole-cell extracts (100 mg) were resolved on 4-20% gradient SDS-PAGE, transferred and immunoblotted with p14ARF, p53 and HDM2 monoclonal antibodies. To demonstrate equal protein loading, blots were probed with actin antibodies. (d) Anti-p14ARF immunoprecipitations were performed and complexes were immunoblotted for p53 and HDM2 following SDS-PAGE. T0 represents the time zero, unirradiated control p14ARF and the DNA damage response S Khan et al within these large nuclear domains ( Figure 2A , panels g-j). Co-staining experiments with p19ARF and B23, a nucleolar marker, confirmed the nucleolar re-localization of p19ARF after irradiation (data not shown).
The specificity of Mab13C5, a monoclonal antibody raised against p14ARF, was first confirmed in the NARF2 system . Importantly, Mab13C5 detected p14ARF only in IPTG-induced NARF2 populations ( Figure 2B) . Similar analyses were then performed using WS1 human fibroblasts.
Staining of unirradiated WS1 cells with Mab13C5 revealed multiple, weak-staining nucleoplasmic 'speckles' ( Figure 2C , panels a, b) in the majority of cells. However, p14ARF staining becomes stronger within 2 h of irradiation ( Figure 2C, panels c, d ). Significantly, 4-6 h after irradiation, p14ARF accumulates in regions of the nucleus that exclude DAPI stain and are reminiscent of nucleoli ( Figure 2C , panels e-h). Nucleolar localization was confirmed by co-staining with antinucleolin (data not shown). At 8 h post-irradiation, the majority of p14ARF localizes within the nucleoli ( Figure 2C , panels i, j). The intense nucleolar p14ARF staining is maintained up to 10 h after irradiation, after which there is a significant diminution of the signal, as ARF redistributes into nucleoplasmic 'speckles' ( Figure 2C , panels k, l). Thus, accumulation of detectable ARF/HDM2 complexes ( Figure 1 ) correlates with the re-localization of p14ARF to the nucleolus 4-6 h post-IR ( Figure 2C ). In multiple experiments, there was a consistent increase in the proportion of cells with re-localized pools of ARF (typically 470-80% showed nucleolar staining), following exposure to IR.
p14ARF nucleolar localization is dependent on p53 function
To examine whether nucleolar re-localization of p14ARF after IR requires an intact p53 pathway, we analysed the localization of p14ARF in irradiated WS1E6 fibroblasts. These cells express HPVE6 and have undetectable levels of p53. Consequently, they do not undergo cell cycle arrest after exposure to Early-passage (p3) MEFs were seeded onto coverslips and irradiated at 7 Gy. They were harvested after 2, 4, 6 and 8 h. Coverslips were stained using polyclonal p19ARF antibodies followed by FITC-conjugated secondary rabbit antibodies. Cells were counterstained with DAPI to identify the nucleoplasmic region. (B) NARF2 cells were seeded onto coverslips and either left untreated or treated with IPTG to induce p14ARF expression. Cells were stained with anti-p14ARF reagents (MAb13C5 in this case) to demonstrate antibody specificity. (C) WS1 fibroblasts were seeded onto coverslips and irradiated at 7 Gy. Coverslips were harvested at several intervals post-IR and stained with p14ARF antisera, followed by DAPI staining. Arrows indicate nucleolar pools of ARF protein Figure 3 p14ARF nucleolar translocation requires a functional p53 pathway. (A) WS1E6 fibroblasts were seeded onto coverslips and irradiated at 7 Gy. Cells were harvested after 2, 4, 6, 8, 14, 16, 18, 20 and 22 h. Coverslips were stained for p14ARF and counterstained with DAPI. (B) WS1E6 cells were electroporated with HDM2 and mutant HDM2 (1-440) expression vectors and seeded onto coverslips. At 7 h prior to harvesting, coverslips were irradiated at 7 Gy. Cells were sequentially stained for p14ARF (Texas red signal) followed by HDM2 (FITC signal) and DAPI. Arrows indicate nucleolar pools of ARF or HDM2 p14ARF and the DNA damage response S Khan et al g-radiation (Kastan et al., 1991; Huang et al., 1996; Linke et al., 1996) . Irradiated WS1E6 fibroblasts have undetectable levels of p53 and HDM2 in p14ARF immune complexes, although ARF is detectable at levels comparable to parental WS1 cells (data not shown). WS1E6 fibroblasts were seeded onto coverslips, irradiated at 7 Gy and harvested at several time points. The intensity of p14ARF staining increases within 2 h of irradiation ( Figure 3A, panels a-d) . However, in contrast to WS1, p14ARF does not re-localize to the nucleolus after IR ( Figure 3A , panels e-j). Instead, the signal remained generally diffuse, yet intense, throughout the nucleus ( Figure 3A, panels c-j) . Significantly, the ARF signal intensity was maintained 22 h after irradiation. Hence, E6 expression can prevent the nucleolar accumulation of p14ARF in response to IR.
Ectopically expressed HDM2 rescues nucleolar localization of p14ARF in WS1E6
Nucleolar localization signals (NoLS) on both ARF and HDM2 are required to target the ARF/HDM2 complex to the nucleolus (Lohrum et al., 2000a, b; Weber et al., 2000) . Since WS1E6 cells lack functional p53, they are unable to induce HDM2 expression following IR. To test the hypothesis that HDM2 is necessary for the nucleolar translocation of p14ARF following IR, irradiated WS1E6 cells were transfected with HDM2 expression constructs. Significantly, p14ARF nucleolar accumulation was restored in WS1E6 cells expressing HDM2, whereas p14ARF remained nucleoplasmic in mock-transfected cells ( Figure 3B , panels a-f). In agreement with previous reports, cells expressing HDM2 1-440 (an HDM2 mutant lacking the C-terminal ring finger domain and cryptic NoLS) did not target p14ARF to the nucleolus ( Figure 3B, panels g-i) . Instead, these cells display diffuse nuclear staining for both ARF and HDM2 1-440. Hence, localization of ARF to the nucleolus may be dependent on nucleolar accumulation of MDM2.
p14ARF binds p53 in the absence of HDM2
The rapid initial interaction between p53 and ARF following irradiation suggests that ARF may exert a direct effect on p53 function in an HDM2-independent manner. p53À/Àmdm2À/À MEFs were infected with adenoviruses expressing human p14ARF and p53, singly and in combination. Significantly, p53 was readily detectable in p14ARF immune complexes isolated from these cells (Figure 4a ), indicating ARF and p53 can interact in the absence of MDM2. To determine if similar HDM2-independent complexes are detectable in human primary cells following IR, WS1 fibroblasts were harvested 2 h post-IR. Lysates were prepared and subjected to three successive anti-HDM2 immunodepletions, followed by an anti-p14ARF immunoprecipitation. Subsequent immunoblotting revealed that HDM2 was efficiently immunodepleted from extracts (Figure 4b ). Importantly, a significant fraction of p14ARF remains associated with p53 in HDM2-depleted extracts (Figure 4b ), suggesting that ARF may exert a direct effect on p53 during the IR response.
Discussion
ARF and p53 function cooperatively during oncogenic transformation and cellular senescence de Stanchina et al., 1998; Palmero et al., 1998; Zindy et al., 1998; Weber et al., 1999) . Initial characterization of ARF-null, murine fibroblasts suggested that an intact response to IR was present in such cells (Kamijo et al, 1997) . However, following ionizing irradiation, ARF-null fibroblasts do not undergo cell cycle arrest, suggestive of an attenuated p53 response (Khan et al., 2000) . Furthermore, as shown in Figures 1  and 4 , ionizing irradiation of human and murine primary fibroblasts induces transient ARF/p53 and ARF/MDM2 interactions. Hence, ARF may be a critical component of the DNA damage response in mammals. Further genetic evidence includes the Figure 4 p14ARF/p53 complex formation in the absence of HDM2. (a) p53À/ÀMdm2À/À MEFs were infected with adenoviruses expressing empty vector (AdVec), p14ARF (Adp14ARF), p53 (Adp53) or both p14ARF and p53 (Adp14ARF þ Adp53). At 24 h post-infection, cells were harvested and p14ARF immunoprecipitations were performed. Blots were probed sequentially with anti-p53 and anti-p14ARF reagents. (b) WS1 fibroblasts were irradiated at 7 Gy and harvested 2 h later. Three successive anti-HDM2 immunoprecipitations were performed to immunodeplete the endogenous HDM2 (aHDM2 #1, #2 and #3). Immunoprecipitation of p14ARF was then performed on the HDM2-depleted extract (ap14ARF*). HDM2-depleted whole-cell extract was also loaded (WCE*). Immunoblotting was performed with monoclonal antibodies against HDM2, p53 and p14ARF as indicated p14ARF and the DNA damage response S Khan et al observation that null mutations in p19ARF complement the premature senescence phenotype displayed by ATMnull MEFs (Kamijo et al., 1999b) . Previously, this rescue had only been observed in ATM-null MEFs lacking either p53 or p21 function (Wang et al., 1997; Xu et al., 1998) . Likewise, p19ARF-null MEFs, expressing adenoviral E1A oncoprotein, are highly resistant to IRinduced apoptosis when compared to wild-type MEFs (de Stanchina et al., 1998) . Moreover, recent data suggest that the suppression of genetic instability arising from telomeric attrition may also be a component of ARF function (Smogorzewska and De Lange, 2002) . Taken together, the genetic and biochemical data support the model that ARF contributes to the p53 response following DNA damage.
The subcellular localizations of ARF and HDM2 have led to a model wherein ARF sequesters HDM2 in the nucleolus to promote p53 stabilization in the nucleoplasm (Weber et al., 1999 ). Yet, p14ARF can also promote p53 stabilization or activation without nucleolar sequestration of HDM2 (Llanos et al., 2001; Korgaonkar et al., 2002) . Both p14ARF and HDM2 co-localize to the nucleolus after IR in primary fibroblasts. Interestingly, ARF contains two putative nucleolar localization signals (Zhang and Xiong, 1999; Weber et al., 2000) , yet nucleolar translocation fails to occur during the DNA damage response in WS1E6 cells. This was rescued by ectopic expression of full-length HDM2. Significantly, the cryptic NoLS in the Cterminus of HDM2 was required to promote nucleolar localization of ARF after irradiation (Figure 3 ). This observation is in broad agreement with previous findings (Lohrum et al., 2000b; Weber et al., 2000) . The data suggest that nucleolar accumulation of ARF with HDM2 is one component of the DNA damage response. However, the peak of detectable ARF/p53 complex formation reproducibly precedes maximal detectable levels of ARF/HDM2 interaction in both human and mouse fibroblasts. Moreover, the peak of ARF/HDM2 complex formation correlates with the appearance and co-localization of both proteins within the nucleolus of human cells. Hence, following IR, significant nucleolar accumulation of p14ARF and HDM2 is apparent during the later stages of the response, after cellular p53 levels reach their peak and are actually in decline. Thus, we hypothesize that increased pools of HDM2 may negatively regulate p14ARF/p53 complexes, perhaps by promoting p14ARF nucleolar localization. In this scenario, HDM2 inhibits the functions of both p53 and p14ARF. Therefore, nucleolar localization of p14ARF may be indicative of a p53 response to IR undergoing downregulation rather than initiation.
Current models of ARF function focus on interactions between ARF and Mdm2, yet ARF can bind p53 directly, in the absence of Mdm2 Zhang et al., 1998;  Figure 4a ). Accordingly, we show that endogenous p14ARF can bind p53 independently of HDM2 (Figure 4b) following IR. Such complexes may represent an immediate-early response to DNA damage. While the exact function of ARF/p53 complexes during the DNA damage response remains to be elucidated, one possibility is that ARF functions as a cofactor for p53 transactivation. Indeed, electrophoretic mobility shift assays demonstrate that p19ARF supershifts p53-DNA complexes, suggesting that ARF is capable of assembling into complexes with p53 on DNA .
The cellular response to IR and DNA damage relies on several signaling pathways to modify p53. These induce downstream protein-protein interactions, ensuring nuclear retention of p53 complexes and transactivation of target genes. Here, we demonstrate that ARF is a component of this signaling mechanism.
Materials and methods

Cell culture
WS1 embryonic fibroblasts (ATCC) and NARF2 cells were cultured in DMEM containing 10% FBS, penicillin/streptomycin and non-essential amino acids. WS1E6 fibroblasts expressing the HPV16 E6 oncoprotein were maintained as described for WS1, supplemented with 200 mg/ml G418. p14ARF expression was induced in NARF2 cells by the addition of 1 mM IPTG. Cells were harvested 18 h postinduction. Human cells were maintained at subconfluency and split in 1 : 4 ratio every 3-4 days. Wild-type, p53À/À and p53À/Àmdm2À/À MEFs were grown in DMEM containing 10% FBS, penicillin/streptomycin and non-essential amino acids. All experiments utilizing wild-type MEFs were completed prior to passage 4. Adenoviruses were infected at multiplicities of infection of two, overnight in complete DMEM media. The supernatants were then removed and the cells placed in fresh complete media for a further 24 h, prior to harvesting.
Antibody development
Monoclonal antibodies (MAbs 13C5, 11D11 and 5C9) were raised against human p14ARF by immunizing BALB/c mice with a His-tagged p14ARF fusion protein. Splenocytes were fused to the SP2 myeloma cell line. Reactive hybridomas were identified by ELISA and screened for the ability to immunoprecipitate in vitro-translated p14ARF. Specificity of the monoclonal reagents was confirmed by IP, Western blot and immunofluorescence using the NARF2, inducible p14ARF system. Polyclonal murine p19ARF antisera were raised against a synthetic peptide comprising amino acids 54-72 (CRRGPHRNPGDDDGQRSRSS) of the murine protein (Research Genetics). This was coupled to keyhole limpet hemocyanin (Pierce), and injected into rabbits (Pocono Rabbit Farms). Peptide antisera were affinity purified against the cognate immunogen (Sulfolink, Pierce).
Protein analysis and immunoprecipitation
WS1 and WS1E6 embryonic fibroblasts were irradiated at 7 Gy using a Cesium 137 irradiator and harvested at several intervals after exposure. Cells were lysed in ice-cold ARF lysis buffer (50 mM HEPES pH 7.5, 350 mM NaCl, 1 mM EDTA, 0.3% NP-40) containing a cocktail of protease inhibitors (Calbiochem). Protein determinations were performed using Bradford assay reagents (Bio-Rad). For Western blotting, whole-cell extracts (100 mg) were separated on SDS-PAGE and subsequently transferred to Immobilon-P membranes using a semi-dry transfer apparatus (Bio-Rad). Immunoprecipitations were performed using B1 mg of wholecell extract. Samples were incubated overnight at 41C with rocking and washed four times in ice-cold medium salt lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.3% NP-40). Immune complexes were separated by SDS-PAGE. Following transfer, blots were blocked in TBS/5% non-fat dried milk/0.05% Tween 20 and probed for p53 (Oncogene Ab6, 1 : 1000), MDM2 (Oncogene Ab1 and/or clone 2A10, kindly provided by Dr Jamil Momand), actin (A2066, Sigma, 1 : 100), or a cocktail of MAb13C5 (1 : 400), 11D11 (1 : 800) and 5C9 (1 : 800) to detect p14ARF. All primary antibodies were diluted in blocking buffer prior to use. HRP-conjugated secondary antibodies (Amersham) were diluted 1 : 2500 in blocking buffer, and blots were incubated for 1 h at room temperature. After extensive washing, chemiluminescent signals were detected using Pierce reagents. For immunoprecipitation of p19ARF, polyclonal antibodies generated in-house were coupled to protein A-sepharose beads and 1 mg of extracts was incubated with 50 ml bead slurry overnight at 41C with rocking. Immune complexes were then washed and analysed as described above. Murine p53 was detected using monoclonal antibody Ab1 (Oncogene, 1 : 10) and p19ARF was detected using Novus Biologicals polyclonal antibody (diluted 1 : 100).
Immunofluorescence analysis
Fibroblasts were seeded onto coverslips, grown overnight at 371C and irradiated the next morning at 7 Gy. Cells were permeabilized prior to fixation as described previously (Rubbi and Milner, 2000) . Briefly, cells were washed once in TBS, once in TBS containing 25% glycerol/0.05 mM EGTA, followed by a 4-min incubation in TBS containing 25% glycerol/0.05 mM EGTA/0.05% Triton X-100. Coverslips were then fixed in 1 : 1 acetone/methanol followed by hydration in PBS. Coverslips were incubated for 1 h at 251C in blocking solution (10% goat serum, 0.5% Tween 20, PBS). Coverslips of NARF2 cells were fixed in 1 : 1 acetone/methanol without permeabilization. For p14ARF single stains, coverslips were incubated for 1 h with MAb13C5 diluted 1 : 200 in PBS/0.5% Tween 20. Unless otherwise stated, all primary and secondary antibody incubations were performed at 251C and coverslips were washed four times in PBS/0.5% Tween 20 after each antibody incubation. Coverslips were stained with FITC-conjugated anti-mouse secondary antibodies (Amersham) diluted 1 : 400 and permanently mounted in medium containing DAPI (Vectashield). For p14ARF/nucleolin co-stains, cells were first stained for p14ARF, followed by an isotype-specific, anti-IgG2a-FITC conjugate (Pharmingen). Cells were then incubated in anti-nucleolin antibody (MBL) diluted 1 : 100, followed by anti-IgG1-biotin diluted 1 : 400 and Texas red-conjugated streptavidin (Amersham) diluted 1 : 400. To stain murine p19ARF, a polyclonal p19ARF antibody (Novus Biologicals) was diluted 1 : 20 in PBS/0.5% Tween 20 and cells were incubated overnight at 41C. FITC-conjugated, anti-rabbit secondary antibodies (Amersham) were diluted 1 : 400 and incubated for 1 h at room temperature. Co-stains of p19ARF and B23 were performed sequentially as described above. Signals were detected using a LEICA confocal imaging system.
Transient transfections
Expression plasmids encoding an empty vector (pcDNA3), full-length HDM2 or HDM2 1-440 lacking the C-terminal ring finger domain were electroporated into 1 Â 10 7 WS1E6 fibroblasts and seeded onto coverslips in six-well dishes. At 7 h prior to harvesting, cells were irradiated at 7 Gy. At 24 h after electroporation, cells were harvested for immunofluorescence analysis as described above. p14ARF/HDM2 co-staining was performed as described for p14ARF/nucleolin, except that antiIgG2b-biotin (1 : 400, Pharmingen) followed by streptavidin -Texas red was used to detect HDM2. HDM2 was detected using Ab1 (Oncogene diluted 1 : 400).
